...hummm,,,I will be very disappointed if the main big deal is less than $100 million,,,,,its peanuts in the biotech world,,,,I get the feeling the muliple facets around this drug combined with multiple suitors who may or may not be interested in the same indications will generally defy comprehension when all is said and done,,,, the start the race might just be the beginning here,,,,,signing of other deals might tend to gather momentum as time rolls on,,,,,no matter what conjecture we take on it will probably not match what is to take place,,,,,